Objective Recent views on schizophrenia outcome and treatment suggest that symptomatic remission is possible, and a definition of remission has been proposed by the Remission in Schizophrenia Working Group (RSWG). This study evaluated whether patients who achieved remission after several years of illness (R) showed psychopathological differences at the onset of their disorder compared to non-remitted (NR) patients. Method Forty-eight patients with first-episode schizophrenia were evaluated with the Positive and Negative Symptoms Scale (PANSS) both at the onset of illness and after a mean period of 16 years. Patients were defined as R or NR according to the RSWG criteria. Results Eighteen patients (37.5%) were classified as R at follow-up. At onset, R patients showed a lower illness severity, less severe negative and general psychopathology symptoms compared to NR. Furthermore, they underwent fewer psychotic episodes than NR over the course of follow-up. Remission was predicted by lower severity of negative and general psychopathology symptoms at onset and by lesser number of psychotic episodes during follow-up. Conclusions The symptomatic remission may be a viable outcome in schizophrenia, particularly for patients with a mild illness and less severe negative symptoms at onset and with few psychotic episodes over time. © 2014 Elsevier Inc.

Predictors of symptomatic remission in patients with first-episode schizophrenia: A 16 years follow-up study / Marchesi, Carlo; Affaticati, Andrea; Monici, Alberto; De Panfilis, Chiara; Ossola, Paolo; Tonna, Matteo. - In: COMPREHENSIVE PSYCHIATRY. - ISSN 0010-440X. - 55:4(2014), pp. 778-784. [10.1016/j.comppsych.2013.12.011]

Predictors of symptomatic remission in patients with first-episode schizophrenia: A 16 years follow-up study

TONNA, MATTEO
2014

Abstract

Objective Recent views on schizophrenia outcome and treatment suggest that symptomatic remission is possible, and a definition of remission has been proposed by the Remission in Schizophrenia Working Group (RSWG). This study evaluated whether patients who achieved remission after several years of illness (R) showed psychopathological differences at the onset of their disorder compared to non-remitted (NR) patients. Method Forty-eight patients with first-episode schizophrenia were evaluated with the Positive and Negative Symptoms Scale (PANSS) both at the onset of illness and after a mean period of 16 years. Patients were defined as R or NR according to the RSWG criteria. Results Eighteen patients (37.5%) were classified as R at follow-up. At onset, R patients showed a lower illness severity, less severe negative and general psychopathology symptoms compared to NR. Furthermore, they underwent fewer psychotic episodes than NR over the course of follow-up. Remission was predicted by lower severity of negative and general psychopathology symptoms at onset and by lesser number of psychotic episodes during follow-up. Conclusions The symptomatic remission may be a viable outcome in schizophrenia, particularly for patients with a mild illness and less severe negative symptoms at onset and with few psychotic episodes over time. © 2014 Elsevier Inc.
55
4
778
784
Predictors of symptomatic remission in patients with first-episode schizophrenia: A 16 years follow-up study / Marchesi, Carlo; Affaticati, Andrea; Monici, Alberto; De Panfilis, Chiara; Ossola, Paolo; Tonna, Matteo. - In: COMPREHENSIVE PSYCHIATRY. - ISSN 0010-440X. - 55:4(2014), pp. 778-784. [10.1016/j.comppsych.2013.12.011]
Marchesi, Carlo; Affaticati, Andrea; Monici, Alberto; De Panfilis, Chiara; Ossola, Paolo; Tonna, Matteo
File in questo prodotto:
File Dimensione Formato  
Marchesi et al_2014.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 156.55 kB
Formato Adobe PDF
156.55 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1120773
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 20
social impact